<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037294</url>
  </required_header>
  <id_info>
    <org_study_id>16-3-036</org_study_id>
    <nct_id>NCT03037294</nct_id>
  </id_info>
  <brief_title>Protein Turnover in the Osteoarthritic Knee</brief_title>
  <acronym>KneeT</acronym>
  <official_title>Protein Turnover in the Osteoarthritic Knee; the Impact of Preoperative Protein Intake and Intra-articular Corticosteroid Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Osteoarthritis (OA) of the knee is a common cause of pain and disability,&#xD;
      especially in people over the age of 65. In the current health care system both conservative&#xD;
      (e.g. intra-articular injections with corticosteroids) and surgical (total knee replacement,&#xD;
      TKR) treatment are applied. Although frequently used, certain effects of these treatments on&#xD;
      protein metabolism remain unclear. It is well known that maintenance of different tissues is&#xD;
      determined by a dynamic balance between protein synthesis and breakdown rates, with temporary&#xD;
      changes in either protein synthesis or breakdown allowing net protein accretion or loss.&#xD;
      Though protein supplementation has shown to be an effective nutritional strategy in&#xD;
      stimulating muscle protein synthesis, it remains unclear to what extent other musculoskeletal&#xD;
      tissues are able to respond to dietary protein supplementation. Therefore, the current study&#xD;
      assesses the impact of preoperative protein supplementation on protein synthesis in different&#xD;
      musculoskeletal tissues of the knee.&#xD;
&#xD;
      Objective: To investigate the effect of preoperative protein supplementation on Hoffa's fat&#xD;
      pad, synovium, tendon, bone, muscle, ligament, menisci, and cartilage protein synthesis of&#xD;
      the OA knee.&#xD;
&#xD;
      Study design: Randomized, parallel (two groups) study design. The intervention group will be&#xD;
      compared to the control group.&#xD;
&#xD;
      Study population: 24 adults with OA of the knee undergoing TKR. Intervention: Daily 40 g of&#xD;
      pre-sleep protein two weeks before TKR or no intervention.&#xD;
&#xD;
      Main study parameters/endpoints: Primary study parameters include protein synthesis rates and&#xD;
      enrichments of Hoffa's fat pad, synovium, tendon, bone, muscle, ligament, menisci, and&#xD;
      cartilage. Secondary parameters include whole-body protein synthesis, breakdown, oxidation,&#xD;
      and net balance.&#xD;
&#xD;
      Nature and extent of the burden and risks associated with participation, benefit and group&#xD;
      relatedness: The risks involved in participating in this study are minimal. There are no&#xD;
      potential effects known for the ingestion of protein. Muscle biopsies and tissue collection&#xD;
      will be performed during the surgical procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in tissue-specific protein synthesis rates</measure>
    <time_frame>Throughout the surgical procedure (stable isotope methodology) and during the 2-week preoperative period (D2O dosing methodology).</time_frame>
    <description>Fractional synthetic rates calculated based on tissue-free, plasma, and protein-bound tracer enrichments using stable isotope methodology and D2O dosing methodology.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Osteo Arthritis Knee</condition>
  <condition>Protein Metabolism</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects in the control group will receive no intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in the protein group will receive a daily 40 g pre-sleep protein supplement during the 2-week preoperative period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Preoperative protein supplementation</intervention_name>
    <description>Daily 40 g of pre-sleep protein supplementation during 2-week preoperative period.</description>
    <arm_group_label>Protein group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Male and female patients scheduled for total knee arthroplasty&#xD;
&#xD;
          -  BMI between 18.5-30 kg/m2&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Mentally competent, as judged by the treating physician&#xD;
&#xD;
          -  Functioning gastrointestinal tract, eligible for oral protein supplementation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Corticosteroid injections less than 3 months prior to participation&#xD;
&#xD;
          -  Any medications know to affect protein metabolism (i.e. corticosteroids, non-steroidal&#xD;
             anti-inflammatories, or prescription strength acne medications)&#xD;
&#xD;
          -  Lactose intolerance&#xD;
&#xD;
          -  Insulin-dependent diabetes mellitus&#xD;
&#xD;
          -  Alcohol abuse&#xD;
&#xD;
          -  Rheumatoid arthritis&#xD;
&#xD;
          -  Peripheral artery disease Fontaine III or IV&#xD;
&#xD;
          -  COPD GOLD III or IV&#xD;
&#xD;
          -  Phenylketonuria&#xD;
&#xD;
          -  Surgical intervention in the past four weeks&#xD;
&#xD;
          -  Total parenteral nutrition at day of surgery&#xD;
&#xD;
          -  Neoadjuvant chemotherapy or radiotherapy&#xD;
&#xD;
          -  GFR &lt;20 mL/min/1.73 m2&#xD;
&#xD;
          -  Osteoarthritis of the knee secondary to septic arthritis, osteonecrosis, fracture, OD,&#xD;
             or malignant processes&#xD;
&#xD;
          -  Collagen disorders, e.g. Marfan and Ehler-Danlos&#xD;
&#xD;
          -  Any other medical condition that may interfere with the safety of the subjects or the&#xD;
             outcome parameters, in the investigators judgement&#xD;
&#xD;
          -  Investigator's uncertainty about the willingness or ability of the subject to comply&#xD;
             with the protocol instructions&#xD;
&#xD;
          -  Participation in any other studies involving investigational or marketed products&#xD;
             concomitantly or within two weeks prior to entry into the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Floris Hendriks, MSc, MD</last_name>
    <phone>+31655522347</phone>
    <email>f.hendriks@maastrichtuniversity.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joey Smeets</last_name>
    <email>joey.smeets@maastrichtuniversity.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <zip>6229ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joey Smeets, MSc, MD</last_name>
      <phone>+31651363946</phone>
      <email>joey.smeets@maastrichtuniversity.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 24, 2017</study_first_submitted>
  <study_first_submitted_qc>January 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2017</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Lex Verdijk</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

